Outcomes Network Graph
Outcomes Flow Chart
Treatment Effectiveness
User reported effectiveness ratings Vyvanse for various conditions.
| Conditions | Major Improvement | Moderate Improvement | Much Worse | No Effect | Worse | Responses |
|---|---|---|---|---|---|---|
| Depression | 14% | 32% | 14% | 36% | 5% | 22 |
Outcomes
Below is the degree of change seen after Vyvanse is higher than average.
|
|
Don't see what you're looking for?
Create a study and help us eradicate suffering!
Daily Distribution
Average by Year
Average by Month
Average by Day of Week
Outcomes Label
Vyvanse Info
| Property | Value |
|---|---|
| Variable Name | Vyvanse |
| Aggregation Method | SUM |
| Analysis Performed At | 2020-10-09 |
| Duration of Action | 21 days |
| Filling Value | 0 |
| Kurtosis | 12.093909170274 |
| Mean | 24.997286666667 milligrams |
| Median | 19.333333333333 milligrams |
| Minimum Allowed Value | 0 milligrams |
| Number of Aggregate Predictors | 0 |
| Number of Aggregate Outcomes | 12 |
| Number of Measurements | 82 |
| Number of Measurements (including those generated by tagged, joined, or child variables) | 82 |
| Public | true |
| Onset Delay | 30 minutes |
| Standard Deviation | 17.710189470003 |
| Unit | Milligrams |
| User Variables | 25 |
| UPC | 637769766115 |
| Variable Category | Treatments |
| Variable ID | 95831 |
| Variance | 560.75213267124 |